China Cancer Immunotherapy Market Accelerates Through Domestic Innovation China has become an increasingly important hub for oncology innovation, particularly in immune checkpoint inhibitor development. Supported by expanding clinical research, regulatory advancements, biotechnology investments, and growing cancer treatment needs, the china immunotherapy drugs market is experiencing continued...